Barinthus Biotherapeutics (BRNS) EBIT (QoQ) (2020 - 2026)
Barinthus Biotherapeutics (BRNS) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.47% |
| Dec 31, 2025 | 23.24% |
| Sep 30, 2025 | 35.41% |
| Jun 30, 2025 | -13.22% |
| Mar 31, 2025 | 11.93% |
| Dec 31, 2024 | -149.36% |
| Sep 30, 2024 | 48.70% |
| Jun 30, 2024 | -8.11% |
| Mar 31, 2024 | 15.38% |
| Dec 31, 2023 | -24.11% |
| Sep 30, 2023 | 38.85% |
| Jun 30, 2023 | -22.59% |
| Mar 31, 2023 | 14.38% |
| Dec 31, 2022 | -446.78% |
| Sep 30, 2022 | -45.33% |
| Jun 30, 2022 | 1,923.70% |
| Mar 31, 2022 | 103.92% |
| Dec 31, 2021 | -201.08% |
| Sep 30, 2021 | 67.14% |
| Jun 30, 2021 | -172.93% |